Design and testing for clinical trials faced with misclassified causes of death

Author： Van Rompaye Bart   Goetghebeur Els   Jaffar Shabbar  

Publisher： Oxford University Press

ISSN： 1465-4644

Source： Biostatistics, Vol.11, Iss.3, 2010-07, pp. : 546-558

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Testing for the Integrity of Blinding in Clinical Trials: How Valid Are Forced Choice Paradigms?

By  

Psychotherapy and Psychosomatics, Vol. 72, Iss. 3, 2003-04 ,pp. : 128-131

Karger

Access to resources Recommend Favorite

Predictive testing and clinical trials in Huntington's disease: An ethical analysis

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. : 243-247

John Wiley & Sons Inc

Access to resources Recommend Favorite

Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia

By Devidas Meenakshi   Anderson James R  

Clinical Investigation, Vol. 3, Iss. 9, 2013-09 ,pp. : 849-858

Future Science

Access to resources Recommend Favorite

New approaches to the design of clinical trials in idiopathic pulmonary fibrosis

By Cerri Stefania   Del Giovane Cinzia   Balduzzi Sara   Soncini Francesco   Sdanganelli Antonia   Richeldi Luca  

Clinical Investigation, Vol. 3, Iss. 6, 2013-06 ,pp. : 531-544

Future Science

Access to resources Recommend Favorite

Expanding the role of `cancer prevention' in clinical trials design and analysis

By Warren Graham W   Marshall James R  

Clinical Investigation, Vol. 3, Iss. 6, 2013-06 ,pp. : 507-510

Future Science

Access to resources Recommend Favorite